Study: NCT04846998

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR9003
Description: Treatment group B:~Once-daily oral administration of one BR9003 2mg tablet in the fasting state.~Treatment group C:~Once-daily oral administration of one BR9003 2mg tablet after a meal(high-fat meal) 30 minutes before the scheduled time of administration and finishing it.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR9003
Description: Treatment group B:~Once-daily oral administration of one BR9003 2mg tablet in the fasting state.~Treatment group C:~Once-daily oral administration of one BR9003 2mg tablet after a meal(high-fat meal) 30 minutes before the scheduled time of administration and finishing it.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR9003
Description: Treatment group B:~Once-daily oral administration of one BR9003 2mg tablet in the fasting state.~Treatment group C:~Once-daily oral administration of one BR9003 2mg tablet after a meal(high-fat meal) 30 minutes before the scheduled time of administration and finishing it.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR9003
Description: Treatment group B:~Once-daily oral administration of one BR9003 2mg tablet in the fasting state.~Treatment group C:~Once-daily oral administration of one BR9003 2mg tablet after a meal(high-fat meal) 30 minutes before the scheduled time of administration and finishing it.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR9003
Description: Treatment group B:~Once-daily oral administration of one BR9003 2mg tablet in the fasting state.~Treatment group C:~Once-daily oral administration of one BR9003 2mg tablet after a meal(high-fat meal) 30 minutes before the scheduled time of administration and finishing it.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR9003
Description: Treatment group B:~Once-daily oral administration of one BR9003 2mg tablet in the fasting state.~Treatment group C:~Once-daily oral administration of one BR9003 2mg tablet after a meal(high-fat meal) 30 minutes before the scheduled time of administration and finishing it.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR9003A
Description: Treatment group A:~Twice-daily oral administration of one BR9003A 1mg tablet in the fasting state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR9003A
Description: Treatment group A:~Twice-daily oral administration of one BR9003A 1mg tablet in the fasting state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR9003A
Description: Treatment group A:~Twice-daily oral administration of one BR9003A 1mg tablet in the fasting state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR9003A
Description: Treatment group A:~Twice-daily oral administration of one BR9003A 1mg tablet in the fasting state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR9003A
Description: Treatment group A:~Twice-daily oral administration of one BR9003A 1mg tablet in the fasting state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR9003A
Description: Treatment group A:~Twice-daily oral administration of one BR9003A 1mg tablet in the fasting state